Ana C Ricardo1, Wei Yang2, Daohang Sha2, Lawrence J Appel3, Jing Chen4,5, Marie Krousel-Wood4,5, Anjella Manoharan6, Susan Steigerwalt7, Jackson Wright8, Mahboob Rahman8, Sylvia E Rosas9, Milda Saunders10, Kumar Sharma11, Martha L Daviglus6, James P Lash6. 1. Department of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois; aricar2@uic.edu. 2. Departments of Medicine and Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Medicine, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland. 4. Departments of Medicine and. 5. Epidemiology, Tulane University, New Orleans, Louisiana. 6. Department of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois. 7. Department of Medicine, University of Michigan, Ann Arbor, Michigan. 8. Department of Medicine, Case Western University, University Hospitals Case Medical Center, Cleveland, Ohio. 9. Department of Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts. 10. Department of Medicine, University of Chicago, Chicago, Illinois; and. 11. Department of Medicine, University of California, San Diego, California.
Abstract
BACKGROUND: In the United States, incidence of ESRD is 1.5 times higher in men than in women, despite men's lower prevalence of CKD. Prior studies, limited by inclusion of small percentages of minorities and other factors, suggested that men have more rapid CKD progression, but this finding has been inconsistent. METHODS: In our prospective investigation of sex differences in CKD progression, we used data from 3939 adults (1778 women and 2161 men) enrolled in the Chronic Renal Insufficiency Cohort Study, a large, diverse CKD cohort. We evaluated associations between sex (women versus men) and outcomes, specifically incident ESRD (defined as undergoing dialysis or a kidney transplant), 50% eGFR decline from baseline, incident CKD stage 5 (eGFR<15 ml/min per 1.73 m2), eGFR slope, and all-cause death. RESULTS: Participants' mean age was 58 years at study entry; 42% were non-Hispanic black, and 13% were Hispanic. During median follow-up of 6.9 years, 844 individuals developed ESRD, and 853 died. In multivariable regression models, compared with men, women had significantly lower risk of ESRD, 50% eGFR decline, progression to CKD stage 5, and death. The mean unadjusted eGFR slope was -1.09 ml/min per 1.73 m2 per year in women and -1.43 ml/min per 1.73 m2 per year in men, but this difference was not significant after multivariable adjustment. CONCLUSIONS: In this CKD cohort, women had lower risk of CKD progression and death compared with men. Additional investigation is needed to identify biologic and psychosocial factors underlying these sex-related differences.
BACKGROUND: In the United States, incidence of ESRD is 1.5 times higher in men than in women, despite men's lower prevalence of CKD. Prior studies, limited by inclusion of small percentages of minorities and other factors, suggested that men have more rapid CKD progression, but this finding has been inconsistent. METHODS: In our prospective investigation of sex differences in CKD progression, we used data from 3939 adults (1778 women and 2161 men) enrolled in the Chronic Renal Insufficiency Cohort Study, a large, diverse CKD cohort. We evaluated associations between sex (women versus men) and outcomes, specifically incident ESRD (defined as undergoing dialysis or a kidney transplant), 50% eGFR decline from baseline, incident CKD stage 5 (eGFR<15 ml/min per 1.73 m2), eGFR slope, and all-cause death. RESULTS:Participants' mean age was 58 years at study entry; 42% were non-Hispanic black, and 13% were Hispanic. During median follow-up of 6.9 years, 844 individuals developed ESRD, and 853 died. In multivariable regression models, compared with men, women had significantly lower risk of ESRD, 50% eGFR decline, progression to CKD stage 5, and death. The mean unadjusted eGFR slope was -1.09 ml/min per 1.73 m2 per year in women and -1.43 ml/min per 1.73 m2 per year in men, but this difference was not significant after multivariable adjustment. CONCLUSIONS: In this CKD cohort, women had lower risk of CKD progression and death compared with men. Additional investigation is needed to identify biologic and psychosocial factors underlying these sex-related differences.
Authors: Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Timothy R Wessel; Christopher B Arant; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko Journal: J Am Coll Cardiol Date: 2006-02-07 Impact factor: 24.094
Authors: Alain G Bertoni; Melicia C Whitt-Glover; Hyoju Chung; Katherine Y Le; R Graham Barr; Mahadevappa Mahesh; Nancy S Jenny; Gregory L Burke; David R Jacobs Journal: Am J Epidemiol Date: 2008-12-15 Impact factor: 4.897
Authors: Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E De Jong; Ronald T Gansevoort Journal: Kidney Int Date: 2008-05-21 Impact factor: 10.612
Authors: James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2009-06-18 Impact factor: 8.237
Authors: Bjørn O Eriksen; Runolfur Palsson; Natalie Ebert; Toralf Melsom; Markus van der Giet; Vilmundur Gudnason; Olafur S Indridason; Lesley A Inker; Trond G Jenssen; Andrew S Levey; Marit D Solbu; Hocine Tighiouart; Elke Schaeffner Journal: J Am Soc Nephrol Date: 2020-06-04 Impact factor: 10.121
Authors: Molly Fisher; Joel Neugarten; Eran Bellin; Milagros Yunes; Lindsay Stahl; Tanya S Johns; Matthew K Abramowitz; Rebecca Levy; Neelja Kumar; Michele H Mokrzycki; Maria Coco; Mary Dominguez; Kalyan Prudhvi; Ladan Golestaneh Journal: J Am Soc Nephrol Date: 2020-07-15 Impact factor: 10.121
Authors: Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Maureen M Achebe; Nwamaka D Eneanya; Ravi I Thadhani; Sagar U Nigwekar; Sahir Kalim Journal: J Am Soc Nephrol Date: 2019-12-06 Impact factor: 10.121
Authors: Nicole K Andeen; Megan L Troxell; Maziar Riazy; Rupali S Avasare; Jessica Lapasia; J Ashley Jefferson; Shreeram Akilesh; Behzad Najafian; Roberto F Nicosia; Charles E Alpers; Kelly D Smith Journal: Clin J Am Soc Nephrol Date: 2019-11-04 Impact factor: 8.237
Authors: Chan-Young Jung; Ga Young Heo; Jung Tak Park; Young Su Joo; Hyung Woo Kim; Hyunsun Lim; Tae Ik Chang; Ea Wha Kang; Tae-Hyun Yoo; Shin-Wook Kang; Joongyub Lee; Soo Wan Kim; Yun Kyu Oh; Ji Yong Jung; Kook-Hwan Oh; Curie Ahn; Seung Hyeok Han Journal: Clin Res Cardiol Date: 2021-05-18 Impact factor: 5.460
Authors: Shelby L Hemker; Débora M Cerqueira; Andrew J Bodnar; Kasey R Cargill; Andrew Clugston; Melissa J Anslow; Sunder Sims-Lucas; Dennis Kostka; Jacqueline Ho Journal: FASEB J Date: 2020-03-05 Impact factor: 5.191